CliffBio
biologic

Human Albumin Grifols

Albumin (Human)

Loss of exclusivityJune 2015projected — 12-year biologic exclusivity estimate
CompanyInstituto Grifols, S.A.

Drug detail

Brand nameHuman Albumin Grifols
Active ingredientAlbumin (Human)
Strength20G/100ML
Dosage formInjection
RouteIntravenous
ModalityBiologic
FDA approvalJune 2003
Marketing statusRx

More from Instituto Grifols, S.A.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Human Albumin Grifols patent cliff — loss of exclusivity June 2015 | CliffBio